Optimizing the Use of PARP Inhibitors in Ovarian Cancer

In this interactive educational activity, expert faculty in the field of ovarian cancer will evaluate the latest recommendation for testing for BRCA1/2 and HRD status in patients with ovarian cancer, compare the established and emerging PARP inhibitors, and evaluate the supporting clinical data supporting their use in ovarian cancer. The faculty will also demonstrate the application of current guidelines and individualization of treatment selection including the optimal use of PARP inhibitors in an in-depth case-based panel discussion.
Educational Partner: Vindico

Medium: Online Module

Commercial Support: This activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

The intended audience for the activity is oncologists, physician assistants, nurse practitioners, and other health care professionals involved in the management of patients with ovarian cancer (OC).

Learning Objectives

After completing this activity, participants will be able to:

  • Summarize the latest recommendations for testing for BRCA1/2 and HRD status in patients with ovarian cancer;
  • Differentiate established and emerging PARP inhibitors based on mechanism, dosing, administration, indication, and safety profile;
  • Apply the latest clinical evidence regarding PARP inhibitors to the individualization of treatment for patients with OC.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Vindico Medical Education
CME Coordinator Contact Email: 
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
Activity opens: 
Activity expires: 
Nita Karnik Lee, MD, MPH
Associate Professor
University of Chicago Comprehensive Cancer Center
Chicago, IL
Kathleen N. Moore, MD, MS
Virginia Kerley Cade Chair in Developmental Therapeutics
Associate Director, Clinical Research
Director, TSET Phase 1 Clinical Trials Unit
Professor, Gynecologic Oncology
Stephenson Cancer Center at the University of Oklahoma
Oklahoma City, OK
Barbara Norquist, MD
Associate Professor
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
University of Washington School of Medicine
Seattle, WA


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION: To view this activity, you will need to visit Vindico's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
Please login or create an account to proceed.